162 related articles for article (PubMed ID: 8185825)
1. Epidermal expression of transforming growth factor-alpha in transgenic mice: induction of spontaneous and 12-O-tetradecanoylphorbol-13-acetate-induced papillomas via a mechanism independent of Ha-ras activation or overexpression.
Wang XJ; Greenhalgh DA; Eckhardt JN; Rothnagel JA; Roop DR
Mol Carcinog; 1994 May; 10(1):15-22. PubMed ID: 8185825
[TBL] [Abstract][Full Text] [Related]
2. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
[TBL] [Abstract][Full Text] [Related]
3. Transgenic coexpression of v-Ha-ras and transforming growth factor alpha increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation.
Wang XJ; Greenhalgh DA; Roop DR
Mol Carcinog; 2000 Mar; 27(3):200-9. PubMed ID: 10708482
[TBL] [Abstract][Full Text] [Related]
4. Cooperation between Ha-ras and fos or transforming growth factor alpha overcomes a paradoxic tumor-inhibitory effect of p53 loss in transgenic mouse epidermis.
Wang XJ; Greenhalgh DA; Donehower LA; Roop DR
Mol Carcinog; 2000 Oct; 29(2):67-75. PubMed ID: 11074603
[TBL] [Abstract][Full Text] [Related]
5. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mice expressing epidermal-targeted v-fos induces rasHA-activated papillomas and carcinomas without p53 mutation: association of v-fos expression with promotion and tumor autonomy.
Greenhalgh DA; Wang XJ; Eckhardt JN; Roop DR
Cell Growth Differ; 1995 May; 6(5):579-86. PubMed ID: 7544154
[TBL] [Abstract][Full Text] [Related]
6. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
[TBL] [Abstract][Full Text] [Related]
7. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
[TBL] [Abstract][Full Text] [Related]
8. Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation.
Shibata MA; Ward JM; Green JE; Merlino G
Mol Carcinog; 1997 Mar; 18(3):160-70. PubMed ID: 9115586
[TBL] [Abstract][Full Text] [Related]
9. Transgenic overexpression of transforming growth factor alpha bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis.
Vassar R; Hutton ME; Fuchs E
Mol Cell Biol; 1992 Oct; 12(10):4643-53. PubMed ID: 1406654
[TBL] [Abstract][Full Text] [Related]
10. Focal transgene expression associated with papilloma development in v-Ha-ras-transgenic TG.AC mice.
Hansen LA; Tennant R
Mol Carcinog; 1994 Mar; 9(3):143-54. PubMed ID: 7908201
[TBL] [Abstract][Full Text] [Related]
11. v-Ha-ras-induced mouse skin papillomas exhibit aberrant expression of keratin K13 as do their 7,12-dimethylbenz[a]anthracene/12-O-tetradecanoylphorbol-13-acetate -induced analogues.
Sutter C; Strickland JE; Welty DJ; Yuspa SH; Winter H; Schweizer J
Mol Carcinog; 1991; 4(6):467-76. PubMed ID: 1724371
[TBL] [Abstract][Full Text] [Related]
12. TGF alpha and v-fos cooperation in transgenic mouse epidermis induces aberrant keratinocyte differentiation and stable, autonomous papillomas.
Wang XJ; Greenhalgh DA; Lu XR; Bickenbach JR; Roop DR
Oncogene; 1995 Jan; 10(2):279-89. PubMed ID: 7530825
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene.
Wei SJ; Chang RL; Merkler KA; Gwynne M; Cui XX; Murthy B; Huang MT; Xie JG; Lu YP; Lou YR; Jerina DM; Conney AH
Carcinogenesis; 1999 Sep; 20(9):1689-96. PubMed ID: 10469612
[TBL] [Abstract][Full Text] [Related]
14. Decreases in phorbol ester-induced papilloma development in v-Ha-ras transgenic TG.AC mice during reduced gene dosage of bcl-2.
Trempus CS; Haseman JK; Tennant RW
Mol Carcinog; 1997 Sep; 20(1):68-77. PubMed ID: 9328437
[TBL] [Abstract][Full Text] [Related]
15. Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas.
Dominey AM; Wang XJ; King LE; Nanney LB; Gagne TA; Sellheyer K; Bundman DS; Longley MA; Rothnagel JA; Greenhalgh DA
Cell Growth Differ; 1993 Dec; 4(12):1071-82. PubMed ID: 8117621
[TBL] [Abstract][Full Text] [Related]
16. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
17. PTEN ablation in Ras(Ha)/Fos skin carcinogenesis invokes p53-dependent p21 to delay conversion while p53-independent p21 limits progression via cyclin D1/E2 inhibition.
Macdonald FH; Yao D; Quinn JA; Greenhalgh DA
Oncogene; 2014 Aug; 33(32):4132-43. PubMed ID: 24037529
[TBL] [Abstract][Full Text] [Related]
18. ROCK2/ras
Masre SF; Rath N; Olson MF; Greenhalgh DA
Oncogene; 2017 May; 36(18):2529-2542. PubMed ID: 27991921
[TBL] [Abstract][Full Text] [Related]
19. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
[TBL] [Abstract][Full Text] [Related]
20. Analysis of c-Ha-ras gene mutations in skin tumors induced in carcinogenesis-susceptible and carcinogenesis-resistant mice by different two-stage protocols or tumor promoter alone.
Pazzaglia S; Mancuso M; Primerano B; Rebessi S; Biozzi G; Covelli V; Saran A
Mol Carcinog; 2001 Feb; 30(2):111-8. PubMed ID: 11241758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
